⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

July 24, 2008Hepatology InternationalOpen Access

A prospective study of antituberculous drug-induced hepatotoxicity in an area endemic for liver diseases

Hoda A. Makhlouf Ahmed Helmy Ehab Fawzy M. El-Attar Hebat Alla G. Rashed

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Anti-TB-DIH is not uncommon, needs early recognition and treatment, and is more in patients with pre-existing liver disease and low BMI.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Makhlouf et al. (2008) studied this question.

synapsesocial.com/papers/69deaac5077ec87fd1e93c2c https://doi.org/10.1007/s12072-008-9085-y

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Pre-pregnancy maternal steatotic liver disease and offspring neurodevelopmental disorders: a nationwide cohort studyHepatology International · 2026
2Contemporary clinical course of compensated advanced chronic liver disease in a multistate frameworkHepatology International · 2026
3Acute-on-chronic liver failure: a global multisociety consensus on definitionsHepatology International · 2026
4Comparative analysis of ctDNA-MRD and MVI in predicting postoperative recurrence of hepatocellular carcinoma: a prospective multicenter cohort studyHepatology International · 2026
5Exploratory analysis of transcriptionally active HBV-host chimeric transcript burden in patients with increasing HBsAg during long-term antiviral therapyHepatology International · 2026
6Randomised trial of lifestyle interventions for improving metabolic dysfunction-associated steatotic liver diseaseHepatology International · 2026
7Clinical and pathological significance of serum anti-PD-1 autoantibodies in acute-onset and chronic autoimmune hepatitisHepatology International · 2026
8Circulating fibronectin levels are linked to liver function, matrix remodeling, and hemostatic complications in advanced chronic liver diseaseHepatology International · 2026
9Coronary atherosclerosis across stages of metabolic dysfunction–associated steatotic liver disease: a VCTE–CCTA studyHepatology International · 2026
10Real-world outcomes of lenvatinib versus sorafenib as the second-line therapy after atezolizumab plus bevacizumab in patients with hepatocellular carcinoma: a large-scale multicenter study in KoreaHepatology International · 2026

More from Hepatology International

More from King Faisal Specialist Hospital & Research Centre

More from Assiut University